Douglas Lane & Associates’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.6M Buy
79,872
+17,362
+28% +$8.16M 0.48% 79
2026
Q1
$24.8M Buy
62,510
+13,780
+28% +$6.23M 0.36% 92
2025
Q4
$22.9M Buy
48,730
+47,890
+5,701% +$21.3M 0.31% 97
2025
Q3
$414K Buy
+840
New +$475K 0.01% 187

Other funds holding SNPS

Douglas Lane & Associates's SNPS Position: Q2 2026 in Review

Douglas Lane & Associates increased its Synopsys (SNPS) stake by 28% in Q2 2026, buying an estimated $8.16M and bringing the position to 79,872 shares worth $35.6M. The position accounts for 0.48% of the portfolio, ranked #79.

Douglas Lane & Associates first reported a position in SNPS in Q3 2025 and has held it in 4 quarters since. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Douglas Lane & Associates held 79,872 shares of Synopsys worth $35.6M as of Q2 2026.
  • Douglas Lane & Associates bought 17,362 Synopsys shares in Q2 2026, an estimated $8.16M.
  • Synopsys made up 0.48% of Douglas Lane & Associates's portfolio in Q2 2026, its #79 holding.
  • Douglas Lane & Associates first reported a position in Synopsys in Q3 2025 and has held it in 4 quarters since.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.